Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Manufacturing

    UDI-DI vs. UDI-PI

    In one line
    Static device identifier (DI) vs. dynamic production identifier (PI) within a UDI.
    Definition
    A Unique Device Identifier comprises two parts: the Device Identifier (UDI-DI), a static code identifying the labeler and device version, and the Production Identifier (UDI-PI), conveying lot/batch, serial, expiration, or manufacturing date. In the US, the DI is submitted to FDA's GUDID database, while the PI stays on the label and in production records. In the EU, the Basic UDI-DI groups device models in EUDAMED and the UDI-DI identifies each package level. Issuing agencies such as GS1, HIBCC and ICCBBA provide the code formats, and changes to certain device features require a new DI.
    Why it matters
    EU MDR introduced the Basic UDI-DI as the master key for regulatory documentation in EUDAMED. Mismatched DI/PI assignments are a common cause of EUDAMED registration errors.
    Common pitfalls
    • •Assigning an incorrect UDI-DI to a device version can lead to significant regulatory non-compliance and recall issues.
    • •Failing to accurately link UDI-PI data to the correct UDI-DI in regulatory submissions creates data integrity problems.
    • •Using UDI-PI elements inappropriately, such as using a lot number field for a serial number, can result in supply chain disruptions.
    • •Not updating UDI-DI data when device design changes occur leads to outdated and misleading product identification.
    • •Disregarding the Basic UDI-DI as the primary key for device registration in EUDAMED can cause extensive administrative burdens.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.